Physician profile
Danh Pham
NPI 1932426269
$2,875.43
in general payments reported to CMS, 2019-2025
12 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $44.80 · 2021: $431 · 2022: $558 · 2023: $514 · 2024: $637 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,408 · Travel and Lodging: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,407.75 |
| Travel and Lodging | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,036.89 | 2019-2025 | Collagenase Santyl |
| Organogenesis INC. | $933.24 | 2019-2025 | Affinity, Via Matrix, Puraply |
| Paratek Pharmaceuticals, INC. | $157.44 | 2019-2024 | Nuzyra |
| Angiodynamics, INC. | $147.14 | 2022 | |
| Next Science LLC | $145.43 | 2023 | Blastx, Xperience, Surgx |
| Kerecis Limited | $137.31 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Convatec INC. | $120.67 | 2023 | |
| Mimedx Group, INC. | $101.81 | 2024 | |
| Abbvie INC. | $31.05 | 2024 | |
| Melinta Therapeutics, LLC | $26.18 | 2019 | |
| Cashflow Solutions, LLC | $20.67 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Integra Lifesciences Corporation | $17.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danh Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.